Vitamin D is an import regulator of T helper 17 (Th17) differentiation, but our understanding of the underlying mechanisms remains limited. In the present study, we aimed to detect the expression levels of microRNAs (miRNAs) during human Th17 differentiation and evaluate the effects of 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ), the bioactive form of vitamin D, on Th17 differentiation and miRNA expression.
Background
T helper 17 (Th17) cells are a subset of CD4+ Th cells characterized by the production of high levels of interleukin (IL)-17A (also known commonly as IL-17) [1] . Besides IL-17A, Th17 cells secret other pro-inflammatory cytokines, such as IL-21, IL-22, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor. Differentiation of naïve CD4+ T cells into Th17 cells requires the coordinated activities of several microenvironmental cues. The cytokines IL-6 and TGF-b induce Th17 cell differentiation by activating retinoid-related orphan receptor (ROR)-gt, a master transcription factor required for the generation of Th17 cells [2] . IL-1b and IL-23 cytokines can promote and stabilize previously differentiated Th17 cells [3] . Accumulating evidence suggests that Th17 cells are major drivers of inflammation and have been implicated in the pathogenesis of multiple autoimmune and immune-mediated inflammatory diseases, including rheumatoid arthritis, multiple sclerosis, asthma, and Behçet's disease [4] [5] [6] [7] [8] . Given the important role of IL-17 cells in regulating autoimmunity and inflammation, elaborating the factors and processes that govern the differentiation of Th17 cells are necessary for developing Th17-targeted therapies.
Vitamin D is an important regulator of the immune system. Almost every immune cell type has been found to express vitamin D receptor (VDR) and/or the enzyme CYP27B1 that is required for the generation of the bioactive form of vitamin D, 1,25(OH) 2 D 3 (also known as calcitriol) [9] . The action of 1,25(OH) 2 D 3 is based on its binding to VDR, which is a liganddependent transcription factor, belonging to the steroid receptor superfamily. Upon ligand binding, VDR undergoes heterodimerization with the retinoid X receptor (RXR) and binds to hormone response elements on DNA, resulting in expression or transrepression of specific gene products [10] . Both in vitro and in vivo studies have found that 1,25(OH) 2 D 3 treatment inhibits T cell commitment to the Th17 lineage as well as Th17 production of IL-17A. 1,25(OH) 2 D 3 directly inhibits Th17 cell differentiation through the VDR signal in CD4+ T cells, independent of the IL-2, IL-10, and STAT1 signals [11] . In addition, 1,25(OH) 2 D 3 suppresses cytokines in Th17 cells by inducing the C/EBP homologous protein (CHOP), a molecule involved in endoplasmic reticulum stress and translational inhibition [12] . Furthermore, 1,25(OH) 2 D 3 inhibits production of IL-17A by blocking nuclear factor for activated T cells (NFAT), recruitment of histone deacetylase (HDAC), sequestration of Runt-related transcription factor 1 (Runx1), and induction of forkhead box P3 (Foxp3), a transcription factor associating with NFAT and Runx1 for transcriptional repression [13] . Although previous studies have obtained some encouraging evidence, our understanding of the mechanisms by which 1,25(OH) 2 D 3 regulates Th17 differentiation remains limited. MicroRNAs (miRNAs) are endogenous, small, non-coding RNAs approximately 22 nucleotides (nt) in length that are highly conserved across various species of eukaryotes. miRNAs posttranscriptionally repress gene expression by binding to complimentary sequences in the 3' untranslated region (UTR) of target messenger RNA (mRNA) [14] . miRNAs are vital for controlling many processes within the immune system including the development and differentiation of lymphocytes, secretion of cytokines and chemokines, antibody switching, and regulation of immune tolerance [15] . Recently, several miRNAs have been implicated in Th17 cell differentiation. miR-155 promotes Th17 cell differentiation and IL-17A production by targeting suppressor of cytokine signaling 1 (SOCS-1), which is a molecule responsible for the negative regulation of the JAK-STAT pathway [16, 17] and suppressing the inhibitory effects of the DNA-binding protein Jarid2 [18] . miR-155-deficient mice show a defect in Th17 differentiation and strong resistance to experimental autoimmune encephalomyelitis (EAE), an experimental animal model for central nervous system demyelinating disease [18, 19] . miR-20b expression is down-regulated in Th17 cells during mouse EAE, and over-expression of miR20b inhibits Th17 differentiation and ameliorates EAE by targeting ROR-gt and STAT3 [20] . In addition, miR-21, miR-181a, miR-210, and miR-301a are found to be involved in the development of Th17 cells [21] [22] [23] [24] [25] .
Since both miRNAs and 1,25(OH) 2 D 3 are crucial regulators of Th17 differentiation, it is of great interest to investigate their interaction in regulating Th17 differentiation. In the present study, we aim to evaluate the expression of several candidate miRNAs during Th17 differentiation and the effects of 1,25(OH) 2 D 3 on Th17 differentiation and miRNA expression.
Material and Methods

Peripheral blood mononuclear cells (PBMC) isolation
Human peripheral blood was obtained by venipuncture from 3 young healthy subjects (LZB, KY, and JFJ) and was collected into K2-ethylene diamine tetraacetic acid (K2-EDTA) vacutainer tubes (Shenzhen Medrey Medical Technology, China). Whole blood (4 mL) was mixed with 4 mL of phosphate-buffered saline and layered gently on 4 mL of lymphocyte separation medium (Dakewe Biotech Company, China) in a 15-mL centrifugate tube. PBMC were separated by using density centrifugation in a 25-min centrifugation step at 2500 rpm at room temperature. The mononuclear layer was collected from the interface of the blood plasma and the separation medium. After separation, PBMC were washed and cultivated at a density of 1.0×10 6 cells/mL in RPMI 1640 (KeyGEN Biotech, China) containing 10% fetal bovine serum, L-glutamine, NaHCO 3 , penicillin, and streptomycin. Cells were incubated in a humidified atmosphere (37°C and 5% CO 2 ).
Th17 cell generation
To generate Th17 cells in PBMCs, anti-CD3 mAb (0.5 ng/L; BioLegend, USA), anti-CD28 mAb (0.5 ng/L; BioLegend, USA), recombinant human IL-1b (rhIL-1b; 100 ng/mL), rhIL-23 (100 ng/mL), rhIL-6 (100 ng/mL), and rhTGF-b1 (25 ng/mL) (all cytokines from PeproTech, USA) were added to the medium on day 0. When 1,25(OH) 2 D 3 (Selleck Chemicals, USA) was used to treat the cells, a final concentration of 100 nM was employed according to the results of our pre-experiments (not shown). After 72 hours of culture, supernatants were collected, and IL-17A production in culture supernatants was analyzed by enzyme-linked immunosorbent assay (ELISA) (Dakewe Biotech Company, China) according to the manufacturer's instructions.
Quantitative PCR (qPCR)
After 72 hours of culture, total RNA containing small-size RNA was isolated from PBMCs using the miRCURY TM RNA Isolation Kit (Exiqon, Denmark). The concentration of RNA was quantified using the NanoDrop 2000 spectrophotometer (Thermo, USA). First strand cDNA synthesis of miRNA was performed with the Mir-X miRNA First-Strand Synthesis Kit (Clontech, Japan). For generating cDNA, 5 µL of 2× mRQ buffer, 1.25 µL of mRQ enzyme, and 3.75 µL of RNA were used, for a total volume of 10 µL. The synthesis reaction was carried out at 37°C for 60 min, followed by 85°C for 5 min. cDNA was diluted with 90 µL of ddH 2 O to bring the total volume to 100 µL after reaction. For miRNA quantification, qPCR analysis was performed using the miR-X miRNA qRT-PCR SYBR Kit (Clontech, Japan) and the CFX96 qPCR system (BioRad, USA). The delta-delta C t method was used to determine the expression of hsa-miR-20b, hsa-miR-21, hsa-miR-155, hsa-miR-181a, hsa-miR-210, and hsamiR-301a normalized against that of U6 snRNA. The 3' primer for qPCR was the mRQ 3' primer supplied with the kit, whereas the 5' primers for miRNAs were designed and synthesized by Takara Biotechnology (Dalian) ( Table 1 ). The forward and reverse primers of U6 were provided with the kit. Reactions were incubated at 95°C for 10 seconds, followed by 40 cycles at 95°C for 5 seconds and 60°C for 20 seconds. Each sample was run in duplicate for analysis. At the end of the PCR cycles, melting curve analysis was performed to ensure the specificity of PCR products. Amplicons were also analyzed by agarose gel electrophoresis and visualized with ethidium bromide under UV transillumination to validate the specific generation of the expected PCR.
Statistical analysis
Data are presented as median with interquartile range (IRQ) and were analyzed by nonparametric statistics with Stata version 11.0. A P value of <0.05 was considered significant. 
Detection of miRNA expression by qPCR
The expression of miRNAs hsa-miR-20b, hsa-miR-21, hsamiR-155, hsa-miR-181a, hsa-miR-210, and hsa-miR-301a was found to be changed under Th17-polarizing conditions. Of these miRNAs, hsa-miR-155 was significantly up-regulated (median fold change: 3.61, P<0.05), whereas hsa-miR-20b, hsamiR-21, hsa-miR-181a, hsa-miR-210, and hsa-miR-301a were significantly down-regulated (median fold change: 0.44, 0.37, 0.18, 0.15, and 0.26, respectively; P<0.05) (Table 2, Figure 2 Figure 2 ). Melting curve analysis and agarose gel electrophoresis of qPCR products confirmed that the amplicons were specific (not shown).
Discussion
The main findings of the present study are as follows: (1) we observed increased expression of hsa-miR-155 and decreased expression of hsa-miR-20b, hsa-miR-21, hsa-miR-181a, hsamiR-210, and hsa-miR-301a during human Th17 differentiation; and (2) miRNAs represent a large family of about 22 nt long, noncoding, single-stranded RNA molecules. In mammals, miRNAs predominantly regulate gene expression by induction of mRNA degradation, and they play an important role in a variety of physiological and pathological processes. An involvement in the regulation of Th17 differentiation has recently been proposed for several miRNAs, including miR-20b, miR-21, miR-155, miR-181a, miR-210, and miR-301a [20] [21] [22] [23] [24] [25] . Given that both 1,25(OH) 2 D 3 and miRNAs are important regulators of Th17 differentiation, it is necessary to evaluate whether 1,25(OH) 2 D 3 affects miRNA expression when exerting its inhibitory effects on Th17 differentiation.
In this study, we focused on six candidate miRNAs, including miR-20b, miR-21, miR-155, miR-181a, miR-210,and miR-301a, based on existing evidence from previous studies showing their relation with Th17 differentiation, rather than performing miRNA microarray analysis to identify candidates, because the former method was more efficient and targeted. In addition, we did not identify candidate miRNAs using in silico analysis because this method was relatively unreliable. The change of miRNA expression during Th17 differentiation was evaluated using qPCR. In agreement with the results from previous studies, all six miRNAs were found to be significantly dysregulated in the development of Th17 cells, with five down-regulated (hsa-miR-20b, hsa-miR-21, hsa-miR-181a, hsa-miR-210, and hsa-miR-301a) and one up-regulated (hsa-miR-155). It was noteworthy that most evidence on expression of miRNAs during Th17 differentiation to date has been derived from results 
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using animal cell cultures [20] [21] [22] [23] 25 ], whereas we evaluated these miRNAs using human cell cultures, which could provide more valuable evidence. In addition, most previous studies concentrated on a single miRNA, but we evaluated several miRNAs simultaneously in this study, which would provide more detailed information on change of miRNA expression during Th17 cell development.
We 
Conclusions
Our study showed that six miRNAs were dysregulated during human Th17 differentiation, with one significantly up-regulated (hsa-miR-155) and five significantly down-regulated (hsamiR-20b, hsa-miR-21, hsa-miR-181a, hsa-miR-210, and hsamiR-301a). 1,25(OH) 2 D 3 did not affect the expression of these miRNAs when suppressing Th17 differentiation.
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